pfizer - Search News

News

Pfizer Raises Profit Outlook

The Wall Street Journal on MSN · 1h

Pfizer Raises Profit Outlook as Uncertainty Lingers Over Tariffs, Drug Prices

Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.

Reuters on MSN · 5h

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer raised its full-year profit forecast on Tuesday while reporting second-quarter results that topped Wall Street estimates, and said it expects to benefit from cost-cutting and a weaker dollar.

MarketWatch on MSN · 1h

Pfizer boosts profit estimate, even as the drug giant absorbs tariffs

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.

Pfizer, Q2

Pfizer beats in Q2 earnings, reaffirms 2025 outlook

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 billion in revenues. The company reported revenues of $14.7 billion, compared to Wall Street expectations of $13.5 billion, and earnings per share of $0.78, versus estimates of $0.58 per share.

Houston Chronicle · 7h

Pfizer: Q2 Earnings Snapshot

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share. The drugmaker posted revenue of $14.65 billion in the period, also topping Street forecasts.

Zacks.com on MSN · 5h

Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates

Pfizer (PFE) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items.

4h

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

13mon MSN

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain.

Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...

Fierce Pharma2h

Pfizer CEO touts 'extremely productive' talks with Trump administration as MFN pricing, tariff threats close in

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

Pfizer CEO in Touch With President Over Most Favored Nation Drug Pricing

Albert Bourla confirmed that he called President Donald Trump after receiving a letter asking Pfizer and a clutch of other ...

2hon MSN

Pfizer CEO says pharma execs discussed Trump’s direct-to-consumer demand

CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S ...

Fierce Biotech5h

Pfizer's embattled obesity program loses another GLP-1 drug

Pfizer has abanonded yet another GLP-1 drug from its shrinking obesity pipeline, as well as dumping a Clostridium difficile ...

4h

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results